Page 2 - Best Ovarian cancer doctors in Turkey: TOP 54 doctors

Specialist Dr. Rahib Hasanov integrates modern treatments like immunotherapies and targeted therapies into personalized oncology care at Hisar Hospital Intercontinental.

• Trained at Istanbul University Cerrahpaşa and Houston Methodist Hospital
• Specializes in gastrointestinal, breast, and urogenital system tumors
• Regularly treats international patients from Europe and the Middle East
• Completed Medical Oncology fellowship at Marmara University

Prof. Mustafa Özdoğan has performed 1,100+ procedures and heads the Medical Oncology Department at Memorial Antalya Hospital.

• 26 years of experience of experience in medical oncology
• Published over 40 articles on cancer treatment
• Member of European and American oncology societies
• Specializes in internal medicine and medical oncology

Dr. Nuri Ceydeli is a gynecologist and obstetrician with over 15 years of experience. He is a graduate of Istanbul University Istanbul Medical School (1995) and Istanbul University Cerrahpaşa Medical School (2002), and is a member of the Turkish Gynecology and Obstetrics Society, Turkish Gynecologic Oncology Society, Surgical Infection Association, and AAGL.

Prof. Sezer Saglam leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital, bringing 29 years of experience of focused experience in ovarian cancer.

• Professor of Medical Oncology since 2016
• Specialized in gastrointestinal oncology at Istanbul University
• Fellowship-trained at Istanbul University Oncology Institute
• Active member of ESMO, ASCO, and ENET societies
• Previously served at American Cancer Center

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Prof. Sadi Kerem Okutur is an associate professor with over 20 years of experience of experience in medical oncology at top hospitals in Turkey.

• Trained at Istanbul University and Istanbul Bilim University
• Member of the European Society for Medical Oncology
• Published 20+ papers and 10 book chapters
• Recipient of the Oncology Research Award

Dr. Mustafa Serkan Alemdar specializes in ovarian cancer treatment with extensive training in medical oncology.

• Over 20 years of experience of experience in medical oncology
• Trained at Akdeniz University, a leading institution in Turkey
• Works at Medical Park Antalya Hospital Complex

Dr. Yildiz is a medical oncologist who specializes in gynecological cancers, including ovarian, based at Medipol Mega University Hospital.

• Over 76 years of experience of experience in oncology with numerous publications
• Author of key research on neuroendocrine and gynecological tumors
• Published case studies on rare ovarian tumors and pregnancy-associated cancers
• Investigates complex cancer-related syndromes and paraneoplastic disorders
• Contributes to multi-center studies on cancer treatment effects

Dr. Sec specializes in complex oncology cases with a focus on ovarian cancer, backed by extensive research and clinical practice.

• Over a decade of experience in medical oncology
• Member of the Turkish Medical Oncology Association
• Published multiple studies on prognostic factors in cancer
• Works at Valued Med Hub Hospitals

Associate Professor Tahsin Ozatli brings years of oncology expertise to Istinye University Liv Hospital Bahcesehir, specializing in breast, lung, and gastrointestinal cancers.

• Trained at Dr. Abdurrahman Yurtaslan Oncology Hospital in Ankara
• Specializes in medical oncology with a focus on comprehensive cancer care
• Promoted to Associate Professor in 2016 for his contributions to oncology

Professor Cemil Bilir combines clinical expertise with advanced research, working at Sakarya University and VM Medical Park Pendik Hospital.

• Specialized in medical oncology with over 21 years of experience of experience
• Trained at Cleveland Clinic and Northeastern University in the U.S.
• Active member of ASCO, ESMO, and TTOD
• Currently pursuing a Ph.D. in Inorganic Chemistry

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Nail Paksoy specializes in ovarian cancer treatment at Istanbul Medipol University Medipol Bahcelievler Private Hospital, with a focus on clinical trials and advanced therapies.

• ESMO Board Certified in Medical Oncology
• Published research on ovarian carcinoma treatment outcomes
• Subinvestigator in multiple international clinical trials

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Gul Alco specializes in radiation oncology for ovarian cancer at Medipol Acibadem District Hospital, with over 31 years of experience of experience.

• Professor at Istanbul Medipol University's Department of Radiation Oncology
• Completed residency at Kadir Has University's Radiation Oncology program
• Associate Professor and later Professor at Demiroglu Bilim University
• Worked at Şişli Florence Nightingale Hospital and Gayrettepe Florence Nightingale Hospital

Dr. Ozden brings over 27 years of experience of medical experience, specializing in oncology with a focus on ovarian cancer at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Extensive experience in internal medicine before specializing in oncology
• Practiced at multiple hospitals, gaining diverse clinical experience

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.